Dilemmas and Innovations in Neurology

* times is according to Israel (UTC/GMT +2)

FRIDAY, OCTOBER 30, 2020

09:00-12:04

DILEMMAS AND INNOVATIONS IN NEUROLOGY

HEBREW SESSION

Chair:

Natan Bornstein, Israel

09:00-09:10

Opening remarks Natan Bornstein, Israel

09:10-09:30

09:30-09:38

Can we prevent relapses in Neuromyelitis Optica Spectrum Disorders (NMOSD)?
Supported by Neopharm Israel
Adi Vaknin-Dembinsky, Israel

Q&A

09:38-09:58

09:58-10:04

From Dementia and MCI to neurocognitive disorders in DSM-5: A whole new ball game
Supported by Dr. Samuelov
Oren Tene, Israel

Q&A

10:04-10:24

10:24-10:32

ADHD : A 24-hour disorder, non-stimulants 24-hour coverage, especially in COVID-19 times
Supported by Unipharm
Gabriel Vainstein, Israel

Q&A

10:32-10:52

10:52-11:00

Importance of early treatment of MS
Supported by Merck Serono
Adi Vaknin-Dembinsky, Israel

Q&A

11:00-11:20

11:20-11:28

Cannabis for diabetic neuropathy
Supported by Teva Israel
Dror Robinson, Israel

Q&A

11:28-11:48

11:48-11:54

Migraine care in the era of COVID-19: Clinical pearls
Supported by Eli Lilly
Oved Daniel, Israel

Q&A

11:54-12:04

Closing remarks
Natan Bornstein, Israel

Headquarters & Administration